BENJAMIN SIMMS CLOYD
Allopathic & Osteopathic Physicians|Internal Medicine NICHOLASVILLE, KY NPI 1356848428
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine KY Lilly USA, LLC All categories
General Payments — all program years on this page
$2,954.58
- Category: General Payments
- Program years: PY2020–2024
- Record count: 168
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,383.01 across 83 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,383.01 | 83 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $351.30 | 21 |
| ABBVIE INC. | $198.02 | 12 |
| PFIZER INC. | $131.34 | 10 |
| Antares Pharma, Inc. | $103.50 | 4 |
| Novo Nordisk AS | $80.83 | 5 |
| Bayer HealthCare Pharmaceuticals Inc. | $77.17 | 5 |
| Amgen Inc. | $60.85 | 4 |
| Acerta Pharma LLC | $51.96 | 3 |
| SANOFI-AVENTIS U.S. LLC | $49.52 | 3 |
| Merck Sharp & Dohme Corporation | $42.65 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $42.29 | 3 |
| GlaxoSmithKline, LLC. | $30.56 | 2 |
| Exact Sciences Corporation | $29.58 | 2 |
| ITI, Inc. | $28.75 | 2 |
| Teva Pharmaceuticals USA, Inc. | $26.65 | 1 |
| DEXCOM, INC. | $24.20 | 1 |
| Dynavax Technologies Corporation | $21.14 | 1 |
| Xeris Pharmaceuticals, Inc. | $19.45 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.25 | 1 |
By program year
Records — PY2024 (83)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.